On Cool Science Radio, Dr. Alex Belser joins the show to discuss psychedelic therapeutics.
Belser has been a leader in the psychedelic research community for the last twenty years. His research has focused on investigating psilocybin and MDMA to treat depression, anxiety, substance use, OCD, PTSD, and end-of-life distress. He has done this research through clinical trials at New York University and Yale University.
Belser is the Chief Clinical Officer of Cybin, a biotech company focused on psychedelic therapeutics.
